HOME > Investors > Press Releases
2018-05-18
Reyon’s Lawsuit Dismissed by Court
2018-05-15
Five Korean Companies’ Stocks Join MSCI Index
2018-05-10
Global Market Report Forecasts ViroMed’s VM202 Will Become First Disease-Modifying Drug for PDPN
2018-04-17
ViroMed’s DPN Clinical Trial Passes 70% Point in Patient Randomization
2018-04-17
ViroMed Announces Publication of VM202’s MoA in Reducing Neuropathic Pain
1 2 3 4 5 6 7 8 9 10